MetaCap

Bullfrog AI (BFRG) vs Kyntra Bio (KYNB)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Bullfrog AI (BFRG) has outperformed Kyntra Bio (KYNB) over the past year, losing 58.2% versus a loss of 81.5%. Bullfrog AI is the larger company by market cap ($6.6 million vs $6.3 million), about 1.1 times the size. Kyntra Bio converts more of its revenue into profit, with a net margin of 2848.6% versus -5569.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BFRG-58.21%KYNB-81.47%
+106%+8%-90%
Nov 21, 20251 yearNov 20, 2026
BFRG-92.53%KYNB-99.74%
+55%-26%-107%
Feb 13, 20235 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BFRG versus KYNB key metrics
MetricBFRGKYNB
Share price$0.3556$1.56
Market cap$6.65M$6.32M
1-day change-8.84%-13.33%
YTD return-59.73%-82.23%
1-year return-58.21%-81.47%
5-year return—-99.49%
EPS (TTM)$-0.41$-4.35
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$116.67K$6.44M
Revenue growth (YoY)—-78.26%
Net income (latest FY)$-6.50M$183.45M
Gross margin18.76%91.37%
Operating margin-5652.38%-712.66%
Net margin-5569.61%2848.63%
52-week high$1.96$10.47
52-week low$0.35$1.56
Distance from 52-week high-81.86%-85.10%
Analyst consensusnonenone
Avg. price target upside—+2442.95%
Average volume5.38M29.96K
Shares outstanding18.69M4.05M
Employees934
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • BFRG has outperformed KYNB by 23.3 percentage points over the past year.
  • Kyntra Bio is more profitable, keeping 2848.6 cents of every revenue dollar as net income versus -5569.6 cents for Bullfrog AI.

About Bullfrog AI

BFRG stock →

Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 9 employees

About Kyntra Bio

KYNB stock →

Kyntra Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing FG-3246, a potential antibody-drug conjugate targeting CD46, for the treatment of metastatic castration-resistant prostate cancer and other cancers.

Health Care · Biotechnology: Pharmaceutical Preparations · 34 employees

BFRG vs KYNB FAQ

Which is bigger, Bullfrog AI or Kyntra Bio?

Bullfrog AI (BFRG) is larger, with a market capitalization of $6.65M compared with $6.32M for Kyntra Bio (KYNB).

Which stock has performed better over the past year, BFRG or KYNB?

BFRG returned -58.21% over the past 12 months, compared with -81.47% for KYNB (price return, excluding dividends). Past performance does not predict future results.

Are Bullfrog AI and Kyntra Bio in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons